We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.45%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$32B
AUM Growth
+$6.48B
(+25%)
Cap. Flow
+$4.77B
Cap. Flow
% of AUM
14.9%
Top 10 Holdings %
Top 10 Hldgs %
10.84%
Holding
2,554
New
720
Increased
686
Reduced
602
Closed
529
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$175M |
| 2 |
Parker-Hannifin
PH
|
+$161M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$149M |
| 4 |
McDonald's
MCD
|
+$138M |
| 5 |
Bank of America
BAC
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$253M |
| 2 |
Meta Platforms (Facebook)
META
|
+$193M |
| 3 |
Lowe's Companies
LOW
|
+$193M |
| 4 |
CME Group
CME
|
+$179M |
| 5 |
Apple
AAPL
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.47% |
| 2 | Consumer Discretionary | 12.5% |
| 3 | Healthcare | 10.55% |
| 4 | Industrials | 6.63% |
| 5 | Real Estate | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PF
351
DELISTED
Pinnacle Foods, Inc.
PF
| $23.5M | 0.07% |
394,348
-159,257
| -29% | -$8.98M |
|
|
BNY
352
Bank of New York Mellon
BNY
$108B
| $23.4M | 0.07% |
434,558
+413,658
| +1,979% | +$22M |
|
353
PUT
Amazon
AMZN
$2.94T
| $23.4M | 0.07% |
+400,000
| New | +$22M |
|
|
MON
354
PUT
DELISTED
Monsanto Co
MON
| $23.4M | 0.07% |
+200,000
| New | +$23.8M |
|
|
ARRY
355
DELISTED
Array Biopharma Inc
ARRY
| $23.3M | 0.07% |
1,822,804
+1,479,245
| +431% | +$16.8M |
|
356
CALL
Bristol-Myers Squibb
BMY
$131B
| $23.3M | 0.07% |
380,000
-170,000
| -31% | -$10.6M |
|
357
Boston Scientific
BSX
$71.4B
| $23.2M | 0.07% |
937,109
-44,815
| -5% | -$1.24M |
|
358
Children's Place
PLCE
$58.9M
| $23.1M | 0.07% |
158,961
-199,728
| -56% | -$24.3M |
|
359
Lazard
LAZ
$4.22B
| $23M | 0.07% |
+438,269
| New | +$21M |
|
|
CELG
360
DELISTED
Celgene Corp
CELG
| $22.9M | 0.07% |
219,291
-87,120
| -28% | -$9.83M |
|
361
Aclaris Therapeutics
ACRS
$851M
| $22.9M | 0.07% |
927,917
+461,340
| +99% | +$11.2M |
|
|
PRAH
362
DELISTED
PRA Health Sciences, Inc.
PRAH
| $22.9M | 0.07% |
250,956
+35,712
| +17% | +$2.97M |
|
363
Tapestry
TPR
$32.7B
| $22.8M | 0.07% |
516,393
+436,615
| +547% | +$18M |
|
|
STAY
364
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $22.8M | 0.07% |
1,199,681
+321,663
| +37% | +$6M |
|
365
Stryker
SYK
$129B
| $22.8M | 0.07% |
146,942
+144,901
| +7,100% | +$22.1M |
|
366
MiMedx Group
MDXG
$609M
| $22.4M | 0.07% |
+1,780,000
| New | +$21.7M |
|
|
VISN
367
Vistance Networks Inc
VISN
$2.28B
| $22.4M | 0.07% |
+591,644
| New | +$20.6M |
|
368
Herbalife
HLF
$1.19B
| $22.3M | 0.07% |
657,510
+616,710
| +1,512% | +$21.6M |
|
369
3D Systems Corp
DDD
$588M
| $22.3M | 0.07% |
+2,575,800
| New | +$26.5M |
|
370
Oracle
ORCL
$413B
| $22.2M | 0.07% |
469,590
-1,229,199
| -72% | -$60.3M |
|
371
HCA Healthcare
HCA
$88.5B
| $21.8M | 0.07% |
248,324
+230,642
| +1,304% | +$18.5M |
|
|
KW
372
DELISTED
Kennedy-Wilson Holdings
KW
| $21.8M | 0.07% |
1,256,991
+1,060,938
| +541% | +$20M |
|
373
Corpay
CPAY
$26B
| $21.7M | 0.07% |
112,904
-279,019
| -71% | -$49.1M |
|
|
ACC
374
DELISTED
American Campus Communities, Inc.
ACC
| $21.7M | 0.07% |
+528,500
| New | +$22.6M |
|
375
Post Holdings
POST
$4.09B
| $21.6M | 0.07% |
417,520
-91,808
| -18% | -$4.88M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2017 Portfolio in Review
As of Q4 2017, Balyasny Asset Management held 2,554 positions worth $32B, up 25% from $25.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management deployed $4.77B of net new capital in Q4 2017, opening 720 new positions and adding to 686 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was American Express, an estimated $253M trimmed.
- Balyasny Asset Management's largest Q4 2017 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
- Balyasny Asset Management added most to Aetna Inc in Q4 2017, an estimated $175M increase.
- Balyasny Asset Management's biggest Q4 2017 reduction was American Express, cutting an estimated $253M.
- Balyasny Asset Management fully exited Range Resources in Q4 2017, selling an estimated $104M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $32B portfolio in Q4 2017.
- Balyasny Asset Management opened 720 new positions and closed 529 in Q4 2017.
- Balyasny Asset Management's portfolio value rose 25% quarter-over-quarter to $32B.
Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.